One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 9 other studies
the abstract, start to end
… eGFR benefit with an odds ratio of 2.3 (CI 0.72-3.9) compared to …
← favours treatmentfavours comparator →
could be chanceKidney outcomes
OR 2.30.72–3.90
SGLT2 inhibitorsKidney outcomes
SGLT2 inhibitors × kidney outcomeshelps?settled
unlikelylikely
0.89not counted
← favours comparatorfavours treatment →
1 / 5